AABB Launches New COVID-19 Convalescent Plasma Website

    AABB recently launched a new website to share information with the public, blood collectors and clinicians about convalescent plasma from individuals who have recovered from COVID-19 (CCP). FDA recently announced new guidelines permitting the use of CCP as an investigational treatment for patients with moderate or severe COVID-19 infections. Many AABB-accredited blood centers are now collecting CCP. The website, COVIDPlasma.org, includes information to help identify eligible CCP donors and a tool to assist those donors in contacting their local blood center or hospital blood collector to schedule a CCP donation. In addition, the website provides CCP resources for blood collectors and the blood community.

    1 Like
    Recent Stories
    AABB Releases Blood Component Cards as Member-Exclusive Offering

    AABB Develops New Fact Sheet for Clinicians Considering CCP to Treat COVID-19

    REGULATORY UPDATE: AABB Resource Highlights Crucial Regulatory Options Already Available from FDA to Support Blood Availability